Stocks
Anika Therapeutics, Inc.ANIK
NASDAQHealthcareBiotechnology$14.20-0.70%
Focused on orthopedic therapies, the company develops and markets hyaluronic acid–based treatments used in osteoarthritis pain management, joint preservation, and regenerative solutions. Its products, including injectable therapies for knee osteoarthritis, are used by orthopedic specialists and spor...
Market Cap: $204.8M52W Range: $7.87 – $16.70
Congressional Interest in Anika Therapeutics, Inc. (ANIK)
2 members of Congress have disclosed 10 trades in Anika Therapeutics, Inc. (ANIK), a Healthcare company. The buy/sell breakdown shows 7 purchases versus 3 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
10
Unique Politicians
2
Buys
7
Sells
3
Who in Congress Is Trading ANIK?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-03-02 | Tom Malinowski | buy | $1K – $15K |
| 2020-02-28 | Tom Malinowski | buy | $1K – $15K |